134 related articles for article (PubMed ID: 37777161)
21. A novel phosphoinositide 3-kinase-dependent pathway for angiotensin II/AT-1 receptor-mediated induction of collagen synthesis in MES-13 mesangial cells.
Yano N; Suzuki D; Endoh M; Zhao TC; Padbury JF; Tseng YT
J Biol Chem; 2007 Jun; 282(26):18819-30. PubMed ID: 17493931
[TBL] [Abstract][Full Text] [Related]
22. Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy.
Chen J; Chen JK; Neilson EG; Harris RC
J Am Soc Nephrol; 2006 Jun; 17(6):1615-23. PubMed ID: 16641152
[TBL] [Abstract][Full Text] [Related]
23. Transactivation of ErbB receptors by leptin in the cardiovascular system: mechanisms, consequences and target for therapy.
Bełtowski J; Jazmroz-Wiśniewska A
Curr Pharm Des; 2014; 20(4):616-24. PubMed ID: 23688012
[TBL] [Abstract][Full Text] [Related]
24. Losartan inhibits EGFR transactivation in vascular smooth muscle cells.
Kırça M; Yeşilkaya A
Turk J Med Sci; 2018 Dec; 48(6):1364-1371. PubMed ID: 30543092
[TBL] [Abstract][Full Text] [Related]
25. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II.
Hunyady L; Catt KJ
Mol Endocrinol; 2006 May; 20(5):953-70. PubMed ID: 16141358
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin II signal transduction in vascular smooth muscle: pathways activated by specific tyrosine kinases.
Berk BC
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S62-8. PubMed ID: 9892142
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphatase.
Shibasaki Y; Matsubara H; Nozawa Y; Mori Y; Masaki H; Kosaki A; Tsutsumi Y; Uchiyama Y; Fujiyama S; Nose A; Iba O; Tateishi E; Hasegawa T; Horiuchi M; Nahmias C; Iwasaka T
Hypertension; 2001 Sep; 38(3):367-72. PubMed ID: 11566906
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin II increases matrix metalloproteinase 2 expression in human aortic smooth muscle cells via AT1R and ERK1/2.
Wang C; Qian X; Sun X; Chang Q
Exp Biol Med (Maywood); 2015 Dec; 240(12):1564-71. PubMed ID: 25767191
[TBL] [Abstract][Full Text] [Related]
29. Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats.
Touyz RM; Wu XH; He G; Salomon S; Schiffrin EL
Hypertension; 2002 Feb; 39(2 Pt 2):479-85. PubMed ID: 11882594
[TBL] [Abstract][Full Text] [Related]
30. Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor.
Kim J; Ahn S; Rajagopal K; Lefkowitz RJ
J Biol Chem; 2009 May; 284(18):11953-62. PubMed ID: 19254952
[TBL] [Abstract][Full Text] [Related]
31. Adrenal angiotensin II type 1 receptor biased signaling: The case for "biased" inverse agonism for effective aldosterone suppression.
Ferraino KE; Cora N; Pollard CM; Sizova A; Maning J; Lymperopoulos A
Cell Signal; 2021 Jun; 82():109967. PubMed ID: 33640432
[TBL] [Abstract][Full Text] [Related]
32. Purinergic P2Y6 receptors heterodimerize with angiotensin AT1 receptors to promote angiotensin II-induced hypertension.
Nishimura A; Sunggip C; Tozaki-Saitoh H; Shimauchi T; Numaga-Tomita T; Hirano K; Ide T; Boeynaems JM; Kurose H; Tsuda M; Robaye B; Inoue K; Nishida M
Sci Signal; 2016 Jan; 9(411):ra7. PubMed ID: 26787451
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.
Mehta PK; Griendling KK
Am J Physiol Cell Physiol; 2007 Jan; 292(1):C82-97. PubMed ID: 16870827
[TBL] [Abstract][Full Text] [Related]
34. Transactivation of ErbB Family of Receptor Tyrosine Kinases Is Inhibited by Angiotensin-(1-7) via Its Mas Receptor.
Akhtar S; Chandrasekhar B; Attur S; Dhaunsi GS; Yousif MH; Benter IF
PLoS One; 2015; 10(11):e0141657. PubMed ID: 26536590
[TBL] [Abstract][Full Text] [Related]
35. Epidermal Growth Factor Receptor Transactivation: Mechanisms, Pathophysiology, and Potential Therapies in the Cardiovascular System.
Forrester SJ; Kawai T; O'Brien S; Thomas W; Harris RC; Eguchi S
Annu Rev Pharmacol Toxicol; 2016; 56():627-53. PubMed ID: 26566153
[TBL] [Abstract][Full Text] [Related]
36. Hybrid formation between the intracellular faces of the bradykinin B2 and angiotensin II AT1 receptors and signal transduction.
Yu J; Prado GN; Taylor L; Pal-Ghosh R; Polgar P
Int Immunopharmacol; 2002 Dec; 2(13-14):1807-22. PubMed ID: 12489795
[TBL] [Abstract][Full Text] [Related]
37. MAPK/AP-1 pathway activation mediates AT1R upregulation and vascular endothelial cells dysfunction under PM2.5 exposure.
Xu X; Xu H; Qimuge A; Liu S; Wang H; Hu M; Song L
Ecotoxicol Environ Saf; 2019 Apr; 170():188-194. PubMed ID: 30529618
[TBL] [Abstract][Full Text] [Related]
38. Critical role of the endogenous renin-angiotensin system in maintaining self-renewal and regeneration potential of epidermal stem cells.
Liao X; Xiao J; Li SH; Xiao LL; Cheng B; Fu XB; Cui T; Liu HW
Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2647-2656. PubMed ID: 31319155
[TBL] [Abstract][Full Text] [Related]
39. Mechanical activation of the angiotensin II type 1 receptor contributes to abdominal aortic aneurysm formation.
Hall S; Ward ND; Patel R; Amin-Javaheri A; Lanford H; Grespin RT; Couch C; Xiong Y; Mukherjee R; Jones JA; Ruddy JM
JVS Vasc Sci; 2021; 2():194-206. PubMed ID: 34761239
[TBL] [Abstract][Full Text] [Related]
40. Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy.
Zuo L; Ushio-Fukai M; Ikeda S; Hilenski L; Patrushev N; Alexander RW
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1824-30. PubMed ID: 15976327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
